Accelerating cancer immunotherapy discovery
AI-powered Design of T-cell-Receptor-based Cancer Immunotherapies
Predict
In silico predictions of therapy side-effects during pre-clinical development
Engineer
Suggestions for molecular modifications to prevent side-effects
Learn
Integration of lab data to improve predictions over time
Meet The Team
Federico Paoletti
CEO & CO-FOUNDER
PhD in Molecular and Computational
Oncology (University of Oxford, UK) and deep
expertise in mathematical modelling and
molecular biophysics.
Andrea Mambrini
CTO & CO-FOUNDER
PhD in Bio-Inspired Computation (University of
Birmingham, UK) and several years of hands-on
experience building cutting-edge AI software
tools across the space, media, automotive and
marketing industries.
Interested?
Contact us using the form below.
Email:
info@exogene.co.uk
Reg. Number:
12293407
Address:
Exogene Limited, Internatonal House, 24 Holborn Viaduct, EC1A 2BN, London, United Kingdom